FDA Disclaimer
Last Updated: October 14, 2025
Operated by: Eunly Limited ("Company", "DERMXELL⁺", "we", "us", or "our")
1. INTRODUCTION AND SCOPE OF APPLICATION
Eunly Limited operates the DERMXELL⁺ website, online store, and associated digital marketing channels (the "Services") to provide customers with premium cosmetic and anti-aging products. This FDA Disclaimer and Regulatory Compliance document governs all product claims, safety information, usage guidelines, and regulatory compliance standards for DERMXELL⁺ Age Defying Lift & Firm Cream and all associated cosmetic products distributed by Eunly Limited.
This disclaimer has been specifically designed to ensure comprehensive compliance with all major advertising platform policies including AppLovin Corporation, Google LLC, Meta Platforms Inc., TikTok, Shopify Inc., and other approved digital advertising networks.
CRITICAL ADVERTISING PLATFORM COMPLIANCE DECLARATION
This FDA Disclaimer document is designed to ensure comprehensive compliance with all major advertising platform health and wellness policies, cosmetic product advertising requirements, and claim substantiation standards effective as of October 2025.
2. MANDATORY FDA DISCLAIMER
2.1 PRIMARY FDA DISCLAIMER (REQUIRED BY LAW)
"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary based on skin type, age, lifestyle, genetic factors, environmental conditions, and adherence to usage instructions."
2.2 COSMETIC PRODUCT CLASSIFICATION
DERMXELL⁺ products are classified as cosmetic preparations under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(i)) and international cosmetic regulations. Our products are NOT:
- Medical devices requiring FDA clearance or approval
- Pharmaceuticals requiring prescription or medical supervision
- Therapeutic goods making disease treatment claims
- Dietary supplements for internal consumption
- Over-the-counter drugs with active pharmaceutical ingredients
3. ADVERTISING PLATFORM COMPLIANCE FRAMEWORK
3.1 APPLOVIN CORPORATION COMPLIANCE
All DERMXELL⁺ advertising through AppLovin's network strictly adheres to AppLovin's Health & Wellness advertising policies. We make no disease treatment claims and all claims are limited to cosmetic benefits only.
3.2 GOOGLE LLC AND YOUTUBE COMPLIANCE
DERMXELL⁺ advertising through Google Ads and YouTube strictly complies with Google's health and beauty product policies. All advertising claims are limited to cosmetic benefits and appearance enhancement.
3.3 META PLATFORMS (FACEBOOK/INSTAGRAM) COMPLIANCE
We strictly comply with Meta's enhanced health and wellness data restrictions effective January 2025. We expressly do not target advertisements based on sensitive health categories.
4. PRODUCT SAFETY AND EFFICACY
4.1 CLINICAL TESTING TRANSPARENCY
DERMXELL⁺ efficacy claims are based on clinical testing, dermatologist-monitored study protocols, and consumer use studies with statistically relevant sample sizes.
4.2 INDIVIDUAL RESULTS VARIATION
Results from DERMXELL⁺ products may vary significantly among individual users based on biological factors (skin type, age, genetics), environmental factors, and usage consistency.
5. INGREDIENT SAFETY
DERMXELL⁺ products are formulated WITHOUT parabens, sulfates, phthalates, artificial fragrances, or animal-derived ingredients. We adhere to Clean Beauty standards and Good Manufacturing Practice (GMP).
6. ADVERTISING CLAIM SUBSTANTIATION
All DERMXELL⁺ advertising claims are supported by independent clinical testing and research. We do NOT claim to treat, cure, or prevent any disease or medical condition.
7. GLOBAL IMPORT COMPLIANCE
DERMXELL⁺ products distributed internationally comply with EU Cosmetic Regulation (EC) No 1223/2009, UK Cosmetic Products Regulation, Health Canada regulations, and Australian TGA standards.
8. CONSUMER PROTECTION
We provide clear usage instructions and safety protocols. Discontinue use immediately if irritation occurs. Consult a healthcare professional if you have known allergies or are pregnant/nursing.
9. LIABILITY LIMITATIONS
Eunly Limited's total aggregate liability for any claims arising from DERMXELL⁺ products shall not exceed the total amount paid by the customer for the specific product giving rise to the claim.
14. CONTACT INFORMATION
Eunly Limited – Regulatory Compliance Office
Email: support@dermxell.com
Phone: +852 6516 5836
Postal Address:
Flat/Rm C1207, 12/F, Hang Cheong Factory Building
1 Wing Ming Street, Cheung Sha Wan, Kowloon
Hong Kong SAR
15. EFFECTIVE DATE
This FDA Disclaimer becomes effective immediately upon publication and supersedes all previous versions. It constitutes a legally binding agreement between Eunly Limited and all users of DERMXELL⁺ products.